AI revolutionizing drug discovery by processing biological data efficiently. AI designing drug molecules to reduce time and cost. AI improving personalized medicine by analyzing patient data. Expect ...

Few would place Recursion Pharmaceuticals ( RXRX +8.44%), a little-known biotech company, in the same league as these tech giants when it comes to AI stocks. But could the small drugmaker actually ...

An announcement from Living Cell Technologies ( ($AU:1AI) ) is now available. Algorae Pharmaceuticals has announced the ...

Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

Conduit Pharmaceuticals Inc. has successfully completed the first phase of its collaboration with Sarborg Limited, aimed at integrating advanced artificial intelligence and cybernetics into its drug ...

TORONTO, Dec. 2, 2025 /CNW/ -- Katalyze AI today announced the appointment of Hannes Bretschneider as Chief AI Officer. Hannes will lead the development of Agentic AI architecture and expand the ...

The study makes clear that regulators expect human oversight to remain central to pharmaceutical quality assurance. Human operators must participate at key control points and retain authority to ...

GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (BFRG) (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using ...

GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty ...

The integration of artificial intelligence (AI) in pharmaceutical research and development (R&D) is transforming the industry. These advancements are not only accelerating drug discovery but also ...

Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to company-specific news or drug announcements, but rather due to actions taken by artificial intelligence ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug ...